🇨🇦 Proudly made in Canada
Back to Learn
The science behind Noomi: what research can (and can’t) say about focus, memory, and stress
Nootropics & Adaptogens

The science behind Noomi: what research can (and can’t) say about focus, memory, and stress

If you’ve ever searched “nootropics for focus,” you’ve seen the pattern:

  • one study gets turned into a guarantee
  • a small effect becomes “life-changing”
  • “in mice” becomes “in humans”
  • and nobody talks about the minimum potency

This article is different. It maps evidences.

  • What researchers measure for focus, memory, and stress
  • What kinds of studies are most useful
  • Where evidence is strong vs messy
  • How Noomi’s ingredient stack lines up with that evidence

A few guardrails up front:

  1. In Canada, health product promotion needs to stay consistent with the product’s authorized therapeutic scope. Claims can be paraphrased, but not stretched, and have to meet a list of minimum requirements.
  2. This article is not about medical advice; it’s a way to read research.
  3. Studies show that cognitive performance peaks and degrades very differently depending on the studied domain, age group, and from one individual to another. It is almost impossible to generalize large segments of the population; and it is for everyone to assess: do they feel less performing than before/usual, and does the adaptogens work on them.

If you want the ingredient-by-ingredient practical explainer, we have gone deeper in "Noomi formula breakdown: practical effects, timelines, and trade-offs". In this post, we stay at the “how evidence works” level.


What “better focus” means in research

“Focus” is vague. Studies don’t measure “focus.” They measure parts of it, like:

  • Attention speed (how quickly you process relevant cues)
  • Inhibitory control (resisting distractions; e.g., Stroop tasks)
  • Working memory (holding and manipulating info short-term)
  • Reaction time and accuracy (often trade-offs)
  • Subjective mental fatigue (how drained you feel)

That’s why you’ll see mixed results across studies. Two trials can both be “about focus” while measuring different things.

Practical takeaway:

  • When a product says “focus,” ask: which part of focus, measured how, in whom, for how long?

 

The five claim domains Noomi aims to support

Noomi’s positioning is a blend of these claim-safe domains:

  1. Supports cognitive function / brain health
  2. Supports memory
  3. Supports mental focus and mental stamina
  4. Helps temporarily promote relaxation
  5. Helps increase energy and resistance to stress over time, addressing fatigue related to stress
  6. helps decrease cognitive fatigue due to physically stressful situations

 

Domain 1: Cognitive function, focus, and mental stamina

What the best evidence usually looks like

  • Randomized, placebo-controlled trials in humans
  • Clear cognitive tasks (Stroop, reaction time, attention batteries)
  • Enough duration to matter (often weeks, sometimes months)
  • Results reported as effect sizes, not just “significant”

Where Noomi’s stack overlaps with human evidence

We have selected multiple ingredients that show signals in human cognition research, but with different strengths and contexts:

  • Bacopa monnieri: Meta-analysis of randomized controlled trials suggests potential cognitive improvement, especially attention speed, while noting the need for larger, better trials. 
  • Alpha-GPC: A 2024 placebo-controlled trial reported improved Stroop performance (a common “focus / inhibitory control” task) in healthy young males after acute supplementation. 
  • L-theanine: A 2019 randomized trial (200 mg/day for 4 weeks) examined stress-related symptoms and included cognition-related outcomes in a non-clinical population. 

How to interpret this domain

  • If you want “I felt it today,” the evidence is usually thinner and more variable.
  • If you want “support over time,” longer trials (weeks+) are more relevant than single-dose studies.

Also: many studies are in narrow populations (young males, students, older adults). That matters for generalizing results.

 

Domain 2: Memory support

Memory is another umbrella term. Studies often split it into:

  • short-term/working memory
  • delayed recall
  • learning rate
  • error rates

Evidence patterns that show up often

  • Bacopa tends to show up more in longer-duration designs (think weeks to months), which lines up with “support” rather than “instant boost.” The meta-analysis above highlights attention speed benefits and the need for stronger trials. 
  • Phosphatidylserine (PS) has human trials in specific contexts. Evidence is mixed across populations, with more positive findings often appearing in older adults or cognitive impairment settings. A 2024 randomized double-blind placebo-controlled trial reported cognitive improvements in an MCI population. 

Practical takeaway:

  • If you’re a healthy adult chasing memory support, expect smaller, harder-to-notice effects than someone with measurable impairment. That’s normal.

 

Domain 3: Stress support, relaxation, and “calm attention”

This is where we believe calmer means smarter:

  • You don’t want to feel sedated.
  • You don't want your brain to keep thrashing.
  • You don't want to be triggered; you want to be aware.

What studies measure here

  • perceived stress scales
  • anxiety symptom scores (in non-clinical or clinical groups)
  • sleep-related measures
  • sometimes biomarkers like cortisol

Evidence overlap in your stack

  • Ashwagandha: Systematic reviews and meta-analyses of RCTs generally show reductions in stress/anxiety measures and sometimes cortisol, with calls for more high-quality long-term research. 
  • L-theanine: The 2019 trial at 200 mg/day for 4 weeks focused on stress-related symptoms in a healthy population with non-clinical complaints, and is commonly cited in discussions of calm/relaxation support. 

What this does not mean:

  • It does not mean “treats anxiety disorders” or replaces therapy.
  • It does not mean “guaranteed better sleep.”

It means that you don't feel at the end of your rope when you need to address a topic. You come to context and situation with more calm, allowing you to unlock your inner wisdom and experience.

 

Domain 4: Cognitive fatigue under physically stressful situations

This is a more specific claim domain, and it has an important nuance:

  • it’s about cognition under stress, not “general everyday focus”

This is where ingredients like tyrosine are often discussed.

What the evidence looks like

  • Cognitive performance after cold exposure, heat, sleep restriction, or demanding tasks
  • Placebo-controlled designs are common, but results vary by stressor

A classic example:

  • A placebo-controlled study reported that tyrosine mitigated working memory decrements during exposure to extreme conditions. 

Also important:

  • Studies' results measuring sport decision-making in intense conditions can vary quite a lot depending on their design and the performance setting.

Practical takeaway:

  • This domain is context-dependent. If your life has acute physical stressors (travel fatigue, demanding training blocks, hard schedules), it’s more relevant than if you’re just “a bit tired.”

 

Domain 5: Energy and resistance to stress over time

This is where marketing often goes off the rails because “energy” sells.

In research, “energy” is usually proxied by:

  • fatigue scales
  • perceived effort
  • sometimes cognitive performance under load

Evidence signals worth knowing

  • Rhodiola rosea: A systematic review concluded evidence is limited by methodological issues, even though some studies suggest potential benefits for mental fatigue. 

Practical takeaway:

  • “Adaptogen” is not a guarantee.
  • Beware stimulants; some formulations while simulate energy using caffeine, lion's mane and other agitators.
  • If someone pretends the evidence is clean, they’re selling you a story.

 

The unsexy truth: dosing, duration, and measurement matter

Three reasons people think “nothing happened”:

  1. They change five things at once (sleep, caffeine, training, supplements), then can’t attribute anything.
  2. They expect a stimulant hit, but the ingredients are about support.
  3. They don’t measure anything, so normal day-to-day variance feels like the product “not working.”

If you want a simple evaluation method:

  • Track one outcome for 2–4 weeks:
    • deep-work blocks completed
    • end-of-day mental fatigue (1–10)
    • a consistent online task (reaction time / Stroop-style test)
  • Keep caffeine timing stable.

We cover specific self-assessment in P-010.

 

How Noomi fits into a workday routine (and why the label wins)

We have designed Noomi for people chosing long term benefits over short-term band aids. 

Here are the basic recommendations to fully experience Noomi's benefits:

  • 4 gummies before starting your day, on workdays; pause on weekends
  • 4 to 6 weeks to see the first benefits stabilize, 3 months to experience the full effects.
  • And of course, take care of yourself:
    • Eat balanced food
    • Sleep at reasonable hours and for a reasonable duration
    • Prioritize at least a bit of exercice, even just a daily walk around the block will do wonders

 

Bottom line

The research on nootropics is not one story. It’s several smaller stories:

  • not all ingredients show consistent signals in specific cognitive domains; the ones we chose for Noomi do
  • effects depend on many criteria: stressors, baseline, sleep, caffeine, age, medical history, study design
  • “cognitive support” is a real category, but it isn’t a miracle

Noomi is built to sit inside that reality:

  • focus + mental stamina support
  • memory support
  • relaxation / stress support
  • energy and stress resistance over time

If you want the ingredient-by-ingredient breakdown next, go to Noomi formula breakdown: practical effects, timelines, and trade-offs.


Get Noomi

noomigummies.com/product

 


 

Sources used in this article

  • Ad Standards, Consumer Advertising Guidelines for Marketed Health Products (claims must not exceed authorized scope). 
  • Health Canada guidance on what counts as promotional advertising. 
  • Bacopa monnieri meta-analysis of RCTs (attention speed signal, limitations). 
  • L-theanine 2019 RCT, 200 mg/day for 4 weeks. 
  • Rhodiola systematic review (contradictory evidence; methodological issues). 
  • Rhodiola trial with negative fatigue outcome in shift-working nursing students. 
  • Ashwagandha systematic review/meta-analysis on stress/anxiety. 
  • Tyrosine and cognition under cold stress (working memory). 
  • Tyrosine null/limited effects example in sport decision-making in heat. 
  • Alpha-GPC acute supplementation trial (Stroop performance). 
  • Natural Health Products Regulations and Health Canada NHP labelling guidance (dose/duration as recommended conditions of use). 
Audrée
Joe

NOTE FROM THE FOUNDERS

We've spent our careers leading teams in high-pressure tech environments. As we hit our late thirties, we both noticed the same thing: it was harder and harder to perform, even though we were in the best shape of our lives. People around us were burned out but expected to just push through. We couldn't understand why there was no legit, simple way to care for our minds that didn't feel like swallowing pills.

Audrée & Jonathan